Clear Search

Books+ Search Results

Subject with Hierarchy: Is
Is Is Not
Pharmaceutical industry
Subject: Is
Is Is Not
Government policy

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Show Online Results Only
Online Results (71)

Limit your search

-
Current results range from 1978 to 2022

1.
The complex web of prescription drug prices : examining agency efforts to further competition and increase affordability : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC, June 19, 2019
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo183063
Location
Yale Internet Resource >> None
Format
Books / Online
2.
Lower drug costs now : expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo182511
Location
Yale Internet Resource >> None
Format
Books / Online
3.
Lower drug costs now : expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington, DC : United States Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.ED 8/1:117-11
Format
Books
4.
Profits over consumers : exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Consumer Protection and Commerce, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo183702
Location
Yale Internet Resource >> None
Format
Books / Online
5.
Profits over consumers : exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Consumer Protection and Commerce, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-63
Format
Books
6.
Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-76
Format
Books
7.
Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo186472
Location
Yale Internet Resource >> None
Format
Books / Online
8.
CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act
Author
Adams, Christopher P.
Published
Washington, D.C. : Congressional Budget Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo158865
Location
Yale Internet Resource >> None
Format
Books / Online
9.
Le droit des affaires pharmaceutiques : vers la caractérisation d'une Lex pharmaceutica?
Published
Paris : LexisNexis, [2020?]
Location
Law Library >> K3636.A6 D76 2020
Format
Books
10.
Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo146986
Location
Yale Internet Resource >> None
Format
Books / Online
11.
Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-25
Format
Books
12.
Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo152475
Location
Yale Internet Resource >> None
Format
Books / Online
13.
Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-21
Format
Books
14.
Description of the revenue provisions of H.R. 3, the "Lower Drug Costs Now Act of 2019" : scheduled for markup by the House Committee on Ways and Means on October 22, 2019
Published
[Washington, D.C.] : [Joint Committee on Taxation], [2019]
Online
https://purl.fdlp.gov/GPO/gpo128577
Location
Yale Internet Resource
Format
Books / Online
15.
Description of the revenue provisions of H.R. 3, the "Lower Drug Costs Now Act of 2019" : scheduled for markup by the House Committee on Ways and Means on October 22, 2019
Published
[Washington, D.C.] : [Joint Committee on Taxation], [2019]
Online
https://purl.fdlp.gov/GPO/gpo128577
Location
Yale Internet Resource >> None
Format
Books / Online
16.
Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2019-
Location
Library Shelving Facility (LSF) >> Y 4.F 49:S.HRG.116-39
Format
Books
17.
EU law of competition and trade in the pharmaceutical sector
Online
Online book
Location
Yale Internet Resource
Format
Books / Online
18.
Examining implementation of the Compounding Quality Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:115-96
Format
Books
19.
Examining implementation of the Compounding Quality Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
https://purl.fdlp.gov/GPO/gpo116408
Location
Yale Internet Resource >> None
Format
Books / Online
20.
Examining the actions of drug companies in raising prescription drug prices : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-01
Format
Books
21.
Examining the actions of drug companies in raising prescription drug prices : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
22.
HIV prevention drug : billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
23.
HIV prevention drug : billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-24
Format
Books
24.
The patient perspective : the devastating impacts of skyrocketing drug prices on American families : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, July 26, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-55
Format
Books
25.
Drug compounding: FDA authority and possible issues for Congress : other title information
Author
Dabrowska, Agata
Published
[Washington, D.C.] : Congressional Research Service, 2018-
Online
https://purl.fdlp.gov/GPO/gpo113854
Location
Yale Internet Resource >> None
Format
Online